Patients with glaucoma who are using prostaglandin F (FP) receptor agonists to control their disease may experience ...

Our vision declines as we age leading to the development of various eye conditions such as presbyopia cataracts and glaucoma ...

In this Healio Video Perspective from Hawaiian Eye 2025, Jason Bacharach, MD, of North Bay Eye Associates, shares data on an aceclidine-based presbyopia-correcting eye drop from Lenz Therapeutics.

Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US. AbbVie is recommending Vuity ...

Medically reviewed by Bryan M. Wolynski, OD Monovision is the name given to the art and science of fitting contact lenses on ...

The FDA has approved the first and so far only pharmacological treatment for presbyopia, a sight condition that typically starts in middle age and involves difficulty in focusing on near objects ...

At Chu Vision Institute, Dr. Jessica Heckman says eyesight does indeed change when people are in their 40s. "It's called ...

008). Topline data were announced from a phase 3 trial evaluating Brimochol TM preservative-free (PF), an investigational pupil-modulating therapeutic, in adults with presbyopia. Study ...

Tenpoint plans to submit an FDA new drug application in the first half of 2025. Patients with presbyopia experienced improvements in near vision after treatment with Brimochol PF in a second phase ...

The merger brings together a late-stage, potentially best-in-class, presbyopia-correcting eye drop, BRIMOCHOL™ PF, on track for NDA filing in 1H, 2025, with a promising pipeline of innovative ...

Further details will be presented at upcoming scientific meetings. "Tenpoint Therapeutics is the only company in the presbyopia category to demonstrate contribution of elements with BRIMOCHOL ...